• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESMED CORP AIRSENSE 11; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESMED CORP AIRSENSE 11; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number DN331
Patient Problems Burning Sensation (2146); Choking (2464); Cough (4457)
Event Date 11/17/2023
Event Type  Injury  
Event Description
Cpap (continuous positive airway pressure) machine started smoking in the middle of the night.I woke up chocking on the smoke from the cpap.I coughed up the smoke out of my lungs.I had an extreme burning sensation in my lungs that lasted about two weeks.My pulmonologist had prescribed "albuterol" sulfate hfa inhalation aerosol (90mcg per actuation) but that didn't work.He has recently prescribed wixela (fluticasone propionate and salmeterol inhalation powder, usp) but that medication is also not working.Made in singapore.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIRSENSE 11
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
RESMED CORP
MDR Report Key18552350
MDR Text Key333517766
Report NumberMW5150592
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 01/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/19/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberDN331
Device Catalogue NumberR390-447/1
Device Lot Number1680634
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
ALBUTERAL SULFATE HFA INHALATION AEROSOL (90MCG PER ACTUATION).; WIXELA (FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER, USP).
Patient Outcome(s) Other;
Patient Age65 YR
Patient SexMale
Patient Weight109 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-